Company Filing History:
Years Active: 2022
Title: Junghak Lim: Innovator in Genome Engineering
Introduction
Junghak Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of genome engineering, particularly through his innovative approaches to enhancing CRISPR-Cas enzymes.
Latest Patents
Lim holds a patent for "Chimeric genome engineering molecules and methods." This patent provides compositions and methods aimed at increasing mutation efficiency and homologous recombination rates of site-specific endonucleases. The invention includes a chimeric polypeptide that comprises a site-specific endonuclease or a domain thereof, along with a functional moiety. The current inventions focus on the functional enhancement of CRISPR-Cas enzymes, and the patent also discloses possible variants and their intended improvements.
Career Highlights
Throughout his career, Junghak Lim has worked with notable organizations such as Gflas Life Sciences, Inc. and Seoul National University. His work has been instrumental in advancing the understanding and application of genome engineering technologies.
Collaborations
Lim has collaborated with several professionals in his field, including Jongjin Park and Ji Young Yoon. These collaborations have contributed to the development of innovative solutions in genome engineering.
Conclusion
Junghak Lim's contributions to genome engineering, particularly through his patent on chimeric genome engineering molecules, highlight his role as a leading inventor in this rapidly evolving field. His work continues to influence advancements in genetic research and applications.